Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEP-A: Brexpiprazole Adjunctive Therapy in Adult ADHD
NCT01074294Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brexpiprazole orally disintegrating tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Mar 2010; status: completed.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01074294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074294.